Biodefense in the Intelligence Age

OpenAI’s biodefense plan signals a major shift toward national-security applications of AI, with significant implications for the 2026 economy. Expect accelerated government contracts, tighter regulation of dual-use biotech AI, and increased R&D spending. Companies positioning AI for early pathogen detection or countermeasure design will gain strategic advantages. This foreshadows a defense-driven AI market expansion beyond commercial use cases.